Sven Perner

University Hospital Schleswig-Holstein

Papers

1

Total Citations

2

H-Index

1

About

Sven Perner is a leading pathologist and translational researcher whose work centers on the molecular pathology of solid tumors, with a particular focus on prostate and head and neck cancers. He is best known for his pioneering contributions to understanding the role of TMPRSS2-ERG gene fusions in prostate cancer, demonstrating how these rearrangements drive oncogenesis and serve as diagnostic and prognostic biomarkers. His research has fundamentally shaped the molecular classification of prostate tumors and opened new avenues for targeted therapy. Perner’s studies are highly influential, with his landmark papers collectively cited over 10,000 times, reflecting their profound impact on the field. Beyond prostate cancer, he has made significant strides in characterizing HPV-positive oropharyngeal cancers, exploring immune microenvironment dynamics and immunotherapy responses. His work on T-cell diversity following Listeria-based immunotherapy for HPV-positive oropharyngeal cancer exemplifies his commitment to translating molecular insights into clinical applications. A prolific author and sought-after collaborator, Perner continues to advance precision oncology through integrated genomic, pathological, and immunological approaches.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Abstract 5639: Changes in local and peripheral T cell diversity after HPV E7 antigen-expressing Listeria-based immunotherapy (ADXS11-001) prior to robotic surgery for HPV-positive oropharyngeal cancer
2 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: University Hospital Schleswig-Holstein

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago